These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22860991)

  • 1. Ocular disorders and the utility of animal models in the discovery of melatoninergic drugs with therapeutic potential.
    Crooke A; Huete-Toral F; Martínez-Águila A; Colligris B; Pintor J
    Expert Opin Drug Discov; 2012 Oct; 7(10):989-1001. PubMed ID: 22860991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin receptors in the eye: location, second messengers and role in ocular physiology.
    Alarma-Estrany P; Pintor J
    Pharmacol Ther; 2007 Mar; 113(3):507-22. PubMed ID: 17229466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin in the eye: implications for glaucoma.
    Lundmark PO; Pandi-Perumal SR; Srinivasan V; Cardinali DP; Rosenstein RE
    Exp Eye Res; 2007 Jun; 84(6):1021-30. PubMed ID: 17174303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circadian rhythms in the eye: the physiological significance of melatonin receptors in ocular tissues.
    Wiechmann AF; Summers JA
    Prog Retin Eye Res; 2008 Mar; 27(2):137-60. PubMed ID: 18316227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of melatonin in the eye and ocular dysfunctions.
    Lundmark PO; Pandi-Perumal SR; Srinivasan V; Cardinali DP
    Vis Neurosci; 2006; 23(6):853-62. PubMed ID: 17266777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role and therapeutic potential of melatonin in age-related ocular diseases.
    Crooke A; Huete-Toral F; Colligris B; Pintor J
    J Pineal Res; 2017 Sep; 63(2):. PubMed ID: 28658514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin as a therapeutic tool in ophthalmology: implications for glaucoma and uveitis.
    Rosenstein RE; Pandi-Perumal SR; Srinivasan V; Spence DW; Brown GM; Cardinali DP
    J Pineal Res; 2010 Aug; 49(1):1-13. PubMed ID: 20492443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin and its analog 5-methoxycarbonylamino-N-acetyltryptamine potentiate adrenergic receptor-mediated ocular hypotensive effects in rabbits: significance for combination therapy in glaucoma.
    Crooke A; Huete-Toral F; Martínez-Águila A; Martín-Gil A; Pintor J
    J Pharmacol Exp Ther; 2013 Jul; 346(1):138-45. PubMed ID: 23591996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin: Implications for Ocular Disease and Therapeutic Potential.
    Scuderi L; Davinelli S; Iodice CM; Bartollino S; Scapagnini G; Costagliola C; Scuderi G
    Curr Pharm Des; 2019; 25(39):4185-4191. PubMed ID: 31724508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular effects of melatonin receptor agonists.
    Paulis L; Simko F; Laudon M
    Expert Opin Investig Drugs; 2012 Nov; 21(11):1661-78. PubMed ID: 22916799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Light, dark, and melatonin: emerging evidence for the importance of melatonin in ocular physiology.
    Brennan R; Jan JE; Lyons CJ
    Eye (Lond); 2007 Jul; 21(7):901-8. PubMed ID: 17001324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of melatonin in experimental free radical-related ocular diseases.
    Siu AW; Maldonado M; Sanchez-Hidalgo M; Tan DX; Reiter RJ
    J Pineal Res; 2006 Mar; 40(2):101-9. PubMed ID: 16441546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of Mel1b melatonin receptor-like immunoreactivity in ocular tissues of Xenopus laevis.
    Wiechmann AF; Udin SB; Summers Rada JA
    Exp Eye Res; 2004 Oct; 79(4):585-94. PubMed ID: 15381042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of melatonin ligands.
    Delagrange P; Boutin JA
    Chronobiol Int; 2006; 23(1-2):413-8. PubMed ID: 16687314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intraperitoneal vitamin E, melatonin and aprotinin on leptin expression in the guinea pig eye during experimental uveitis.
    Kükner A; Colakoğlu N; Serin D; Alagöz G; Celebi S; Kükner AS
    Acta Ophthalmol Scand; 2006 Feb; 84(1):54-61. PubMed ID: 16445440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis.
    Myles ME; Neumann DM; Hill JM
    Adv Drug Deliv Rev; 2005 Dec; 57(14):2063-79. PubMed ID: 16310884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and quantitation of carotenoids and their metabolites in the tissues of the human eye.
    Bernstein PS; Khachik F; Carvalho LS; Muir GJ; Zhao DY; Katz NB
    Exp Eye Res; 2001 Mar; 72(3):215-23. PubMed ID: 11180970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin: Unveiling the functions and implications in ocular health.
    Zhang J; Zhou H; Cai Y; Yoshida S; Li Y; Zhou Y
    Pharmacol Res; 2024 Jul; 205():107253. PubMed ID: 38862072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin in cardiovascular disease.
    Dominguez-Rodriguez A
    Expert Opin Investig Drugs; 2012 Nov; 21(11):1593-6. PubMed ID: 22916801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.